Sector: Pharmaceuticals & Biotechnology

Small Cap

Onyx Biotec Share Price

Q: What is the Market Capitalization of Onyx Biotec Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Onyx Biotec Ltd. is approximately ₹ 66.1 Cr.

Q: What are the PE and PB ratios for Onyx Biotec Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Onyx Biotec Ltd. is -308.3, and the Price-to-Book (PB) ratio is 1.2.

Q: What is the 52-Week High and Low for Onyx Biotec Ltd.?

Over the past 52 weeks, the highest price reached by Onyx Biotec Ltd. shares was ₹ 53.9, and the lowest price was ₹ 24.2.

Q: Who are the major shareholders of Onyx Biotec Ltd.?

Significant shareholdings in Onyx Biotec Ltd. typically include entities such as: Promoter Public Other Institutions FII (Note: Shareholding patterns can change; this represents major holders based on recent filings).

Q: Who are the peers of Onyx Biotec Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Onyx Biotec Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

ONYX

₹37.05

0.60(1.65%)

24th Jul 2026 | 9:30 AM

NSE : ONYX

Open Free Demat Account

Onyx Biotec Performance

Price Movement

₹37.05

₹35.20

₹37.05

↘ Today's Low↗ Today's High

1 Year Performance

₹37.05

₹24.20

₹53.90

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹37.05

Low₹35.20

Open at₹35.20

Prev Close₹36.45

Volumes6.00 K

Avg Price₹35.91

Lower Circuit₹34.65

Upper Circuit₹38.25

Historical Performance

3M High₹45.00

3M Low₹24.20

1 Yr High₹53.90

1 Yr Low₹24.20

3 Yr High₹97.45

3 Yr Low₹24.20

5 Yr High₹97.45

5 Yr Low₹24.20

Summary

As of 24-07-2026 09:35, Onyx Biotec Ltd. share price today is ₹0, with a change of ₹-36.45 (-100.00%) from the previous close of ₹36.45. The stock opened at ₹35.2 and traded between ₹35.2 and ₹37.05, with a total traded volume of 6000 shares. The company has a market capitalization of ₹66.1 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹53.9 and ₹24.2, respectively.

Onyx Biotec Ltd. valuation metrics include a P/E ratio of -308.3, and book value of ₹1.20. Profitability indicators show ROE of -0.38%.

Onyx Biotec Ltd. technical indicators include Day RSI at 44.68, Day MFI at 44.18, Day ADX at 14.25. Additional indicators include Commodity Channel Index (CCI) at -107.8 and Williams %R at -96.12. Momentum indicators show Day MACD at -0.26, Day MACD Signal Line at 0.09, DayATR at 1.7. Rate of Change indicators for Onyx Biotec Ltd. include ROC125 at 17.58 and ROC21 at -10.99.

Exponential moving averages include EMA5 at ₹37.3, EMA10 at ₹37.8, EMA12 at ₹37.9, EMA20 at ₹38.2, EMA26 at ₹38.1, EMA50 at ₹37.6, EMA100 at ₹37.2, EMA200 at ₹40. Simple moving averages include SMA5 at ₹37.3, SMA10 at ₹37.8, SMA20 at ₹38.8, SMA30 at ₹38.6, SMA50 at ₹37.5, SMA100 at ₹35.6, SMA150 at ₹35.7, SMA200 at ₹37.9.

Support levels for Onyx Biotec are placed at First Support ₹36.13, Second Support ₹35.82, Third Support ₹35.38. Resistance levels are seen at First Resistance ₹36.88, Second Resistance ₹37.32, Third Resistance ₹37.63. Onyx Biotec Ltd. shareholding pattern shows promoter holding at 65.1%, FII holding at 1.07%, DII holding at 0%, public holding at 31.44%.

Onyx Biotec Fundamentals

Market Cap

Low in industry

66.10 Cr.

PE Ratio (TTM)

Negative PE TTM

-308.30

Dividend Yield

Net Profit TTM

Net profit TTM

Net Profit Growth

Net profit TTM

PEG Ratio

ROE

104% decr over last year

-0.38

Operating Revenue TTM

Operating Revenue Growth

Operating Revenue TTM

Book Value

Low in industry

1.20

MFI

MFI is mid-range

44.18

RSI

RSI is mid-range

44.68

EPS (TTM)

Debt to Equity

Face Value

Operating Profit Margin Qtr.

Operating Profit Qtr.

Net Profit Qtr.

Operating Revenue Qtr.

PB Ratio

1.20

Onyx Biotec Financials

Data not available for chart

Indicator
No Record Found

Onyx Biotec Technicals

Onyx Biotec Ltd. EMA & SMA

₹37.05

-0.55 (-1.46%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹37.3

Day EMA10 ₹37.8

Day EMA12 ₹37.9

Day EMA20 ₹38.2

Day EMA26 ₹38.1

Day EMA50 ₹37.6

Day EMA100 ₹37.2

Day EMA200 ₹40

Onyx Biotec Support and Resistance

Resistance

First Resistance₹36.88

Second Resistance₹37.32

Third Resistance₹37.63

Support

First Support₹36.13

Second Support₹35.82

Third Support₹35.38

Technical Indicators

Day RSI44.68

Day MFI44.18

Day ADX14.25

Day Commodity Channel Index-107.80

William-96.12

Day MACD-0.26

Day MACD Signal Line0.09

Day ATR1.70

Day ROC12517.58

Day ROC21-10.99

Onyx Biotec Shareholding Pattern

Held By	Mar 2025	Sep 2025	Mar 2026
Promoter	65.1	65.1	65.1
FII	5.4	2	1.1
DII	2.4	2.3	2.4
Public	27.2	30.6	31.4

Onyx Biotec Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	6 K	6 K	100.00%
Week	5.6 K	6 K	93.33%
1 Month	31.43 K	32.19 K	97.63%
6 Month	53.42 K	54.98 K	97.17%

Onyx Biotec SWOT Analysis

Strengths4

Weakness9

Opportunity0

Threats0

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Companies with Low Debt

Companies with Zero Promoter Pledge

Stock with Low PE (PE < = 10)

Onyx Biotec Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
No Record Found

Onyx Biotec Stock Comparison

Financials	Bio Medica Laboratories Ltd.	Sai Parenterals Ltd.	Vivimed Labs Ltd.	Curis Lifesciences Ltd.	Amanta Healthcare Ltd.	Anlon Healthcare Ltd.
Price (₹)	₹138.80	₹539.10	₹5.25	₹112	₹163	₹15.10
% Change	-0.11%	-0.11%	1.55%	1.82%	-1.81%	0.13%
Revenue TTM (₹ Cr)	-	-	₹69.99	-	₹287.68	₹176.50
Net Profit TTM (₹ Cr)	-	-	₹-176.47	-	₹14.88	₹27.81
PE TTM	66.40	-	-0.20	12.90	43.30	28.80
1 Year Return	-0.04	37.68	417	-14.06	31.75	65.71
ROCE	-	3.56	-56.37	-	-	17.36

Similar Stocks

MEDISTEP

Medistep Healthcare Ltd.

₹ 19.75

-1.25%

INFLUX

Influx Healthtech Ltd.

₹ 290.10

-0.31%

MEDIORG

Medicamen Organics Ltd.

₹ 24.70

-5.00%

AMRUTANJAN

Amrutanjan Health Care Ltd.

₹ 506.00

-2.65%

VALIANTLAB

Valiant Laboratories Ltd.

₹ 61.75

-0.82%

SIGACHI

Sigachi Industries Ltd.

₹ 25.50

-2.00%

WINDLAS

Windlas Biotech Ltd.

₹ 856.00

-0.63%

VINEETLAB

Vineet Laboratories Ltd.

₹ 38.60

+3.21%

SOLARA

Solara Active Pharma Sciences Ltd.

₹ 495.00

-5.49%

ZIMLAB

Zim Laboratories Ltd.

₹ 120.40

+1.30%

MEDICO

Medico Remedies Ltd.

₹ 37.93

-0.94%

DCAL

Dishman Carbogen Amcis Ltd.

₹ 183.41

+2.33%

LASA

Lasa Supergenerics Ltd.

₹ 6.97

-1.83%

ADVENZYMES

Advanced Enzyme Technologies Ltd.

₹ 317.55

+1.05%

BAJAJHCARE

Bajaj Healthcare Ltd.

₹ 325.00

+2.30%

ORTINGLOBE

Ortin Global Ltd.

₹ 14.70

-1.41%

BROOKS

Brooks Laboratories Ltd.

₹ 64.40

-2.39%

RPGLIFE

RPG Life Sciences Ltd.

₹ 2970.00

+2.33%

BAFNAPH

Bafna Pharmaceuticals Ltd.

₹ 238.15

-2.00%

ALPA

Alpa Laboratories Ltd.

₹ 66.33

-0.72%

SMSPHARMA

SMS Pharmaceuticals Ltd.

₹ 385.95

+0.34%

NECLIFE

Nectar Lifesciences Ltd.

₹ 10.30

-0.58%

MANGALAM

Mangalam Drugs and Organics Ltd.

₹ 27.10

-0.26%

INDOCO

Indoco Remedies Ltd.

₹ 243.00

+2.04%

FAQ's on ONYX

What is the Market Capitalization of Onyx Biotec Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Onyx Biotec Ltd. is approximately ₹ 66.1 Cr.

What are the PE and PB ratios for Onyx Biotec Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Onyx Biotec Ltd. is -308.3, and the Price-to-Book (PB) ratio is 1.2.

What is the 52-Week High and Low for Onyx Biotec Ltd.?

Over the past 52 weeks, the highest price reached by Onyx Biotec Ltd. shares was ₹ 53.9, and the lowest price was ₹ 24.2.

Who are the major shareholders of Onyx Biotec Ltd.?

Significant shareholdings in Onyx Biotec Ltd. typically include entities such as:

Promoter
Public
Other Institutions
FII

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Onyx Biotec Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Onyx Biotec Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy